Glaukos Corp., an eye device startup in Laguna Hills, said Thursday that it has raised $29.5 million in a fifth round of venture capital funding, according to a report on Thousand Oaks-based news site SoCalTech.com.
Glaukos is working on a medical device that can be implanted in the eye to treat glaucoma, a major cause of blindness.
Meritech Capital Partners of Palo Alto led Glaukos’ latest funding, contributing $16 million of the round.
Returning investors also participated, including Versant Venture Management LLC, which has an office in Newport Beach, and Domain Associates, which was once located in Laguna Hills and is now based in San Diego.
Glaukos’ management team includes several veterans of Orange County medical device and drug makers such as Allergan Inc. and Edwards Lifesciences Corp., both of Irvine, and Santa Ana-based Advanced Medical Optics Inc., which now is Abbott Medical Optics Inc.
The company’s founders include Olav Bergheim, a longtime life science entrepreneur, and Richard Hill, an ophthalmologist at the University of California, Irvine.
